Phase II trial of piritrexim and DTIC using an alternating dose schedule in metastatic melanoma

L. G. Feun, W. A. Robinson, N. Savaraj, R. Gonzalez, A. Liebmann, K. Offenhauser, N. J. Clendeninn

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of piritrexim and DTIC using an alternating dose schedule in metastatic melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences